Percutaneous absorption of interferon-α by self-dissolving micropiles
Authors:
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 16 (3) , 243-249
Abstract
To ascertain the pharmaceutical usefulness of self-dissolving micropiles (SDMPs) containing interferon (IFN), two types of SDMPs were prepared using chondroitin sulfate and dextran as the base. After percutaneous administration of 5000 IU/kg IFN-α2b SDMP to rats, serum IFN levels were measured for 6 h. The peak serum IFN level, maximum drug concentration (Cmax), and the time when serum IFN level reaches to Cmax, time to reach maximum concentration (Tmax), were 8.2 ± 0.5 IU/ml and 1.2 ± 0.1 h, respectively, for chondroitin SDMP. For dextran SDMP, Cmax and Tmax were 3.1 ± 0.4 IU/ml and 3.3 ± 0.3 h, respectively. AUC of chondroitin SDMP was 1.5 times greater than that of dextran SDMP. Bioavailabilities (BAs) of IFN were 378.3% for chondroitin SDMP and 255.9% for dextran SDMP that were larger than 100%. The BA of IFN from subcutaneous (s.c.) injection solution was 320.9%. The relative BAs of IFN SDMPs against s.c. injection solution were 117.8% for chondroitin SDMP and 79.9% dextran SDMP. An in vitro release experiment suggested the faster release rate of IFN from chondroitin SDMP, 57.3% at 5 min, than dextran SDMP, 32.6% at 5 min. Chondroitin SDMP containing IFN showed good stability for 3 months and no damage to the administered rat skin.Keywords
This publication has 27 references indexed in Scilit:
- Absorption of interferon alpha from patches in ratsJournal of Drug Targeting, 2005
- Microneedles for transdermal drug deliveryAdvanced Drug Delivery Reviews, 2004
- A tapered hollow metallic microneedle array using backside exposure of SU-8Journal of Micromechanics and Microengineering, 2004
- Surface micromachined metallic microneedlesJournal of Microelectromechanical Systems, 2003
- Peginterferon alpha-2b: a new approach to improving response in hepatitis C patientsExpert Opinion on Pharmacotherapy, 2001
- A Case of Interferon Alpha-Induced Manic Psychosis in Chronic Hepatitis C.The Tohoku Journal of Experimental Medicine, 1999
- Development and Evaluation of Noncompartmental Pharmacokinetic Analysis Program "WinHARMONY" Using Visual BASIC Language Having a Function of an Automatic Recognition of Terminal Elimination Phase of Plasma Drug Concentration vs. Time Profile.Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1998
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994
- A Patient with Chronic Hepatitis C Who Simultaneously Developed Interstitial Pneumonia, Hemolytic Anemia and Cholestatic Liver Dysfunction after Alpha-Interferon Administration.Internal Medicine, 1994
- Mechanism of the Antitumour Effect of Interferon in MiceNature, 1972